Omega-3 Market

The omega-3 market is projected to experience a robust compound annual growth rate (CAGR) of 12.3%, increasing from USD 4.88 billion in 2026 to USD 8.73 billion by 2031. Rising awareness among consumers about cardiovascular health, brain function, eye health, and overall wellness, coupled with the growing demand for natural and functional ingredients, is expected to drive demand for omega-3 in the coming years. Omega-3 ingredients are gaining significant traction due to their clinically proven health benefits and wide range of applications. As the food and beverage, nutraceutical, and dietary supplement industries continue to expand, omega-3 products in concentrated and innovative forms are witnessing increasing adoption. Moreover, the use of omega-3 is expanding in pharmaceuticals, infant nutrition, and animal feed, further driving market development and creating new opportunities globally.

Collaborations between food tech companies, pharmaceutical players, aquaculture firms, and biotech researchers are accelerating advancements in omega-3 extraction, purification, and formulation. These partnerships are enabling the development of sustainable sources such as algae-based omega-3, alongside traditional fish oil and krill oil, broadening their accessibility across various consumer bases. Functional foods and beverages, dietary supplements, fortified dairy, and skincare products are increasingly incorporating omega-3, positioning it as a versatile and reliable ingredient. With a growing shift toward preventive healthcare and sustainable nutrition, the demand for omega-3 is expected to increase significantly, supported by its proven efficacy and the rising demand for clean-label, science-backed products.

To know about the assumptions considered for the study download the pdf brochure

Market growth is driven by several factors, including rising consumer awareness of cardiovascular health, brain development, and overall wellness, increasing prevalence of lifestyle-related disorders such as obesity, diabetes, and heart disease, and the growing demand for functional foods and dietary supplements. The role of omega-3 in supporting heart, eye, cognitive, and joint health is well-established, and omega-3 ingredients are increasingly being incorporated into food and beverages, supplements, pharmaceuticals, and personal care products. Owing to their strong global presence, some of the major players in the omega-3 market include Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK). These companies employ a combination of organic and inorganic growth strategies, including partnerships, acquisitions, product launches, facility expansions, and collaborations, to strengthen their market position and meet the growing demand worldwide.

Scientific research, clinical trials, and advanced extraction and purification technologies, particularly in sustainable sources like algae-derived omega-3, are being increasingly utilized by leading players to enhance product efficacy, stability, and bioavailability. This is creating a strong growth platform for omega-3 across functional food, dietary supplements, pharmaceuticals, pet nutrition, and personal care industries.

DSM-Firmenich

DSM-Firmenich is a global science-based health, nutrition, and beauty company formed through the May 2023 merger of DSM and Firmenich. Through its Health, Nutrition & Care segment, the company offers a broad portfolio of omega-3 ingredients for dietary supplements, infant nutrition, fortified foods, pharmaceuticals, and animal nutrition, sourced from both fish oil and algae. Operating across four business segments, DSM-Firmenich has a strong global presence with over 200 sites and offices in nearly 50 countries across North America, Europe, Latin America, Asia Pacific, and Africa.

In April 2026, DSM-Firmenich launched Veramaris O3 Max Pure at Petfood Forum 2026, introducing the world's first microalgal omega-3 oil that replicates the natural 3:2 EPA:DHA ratio found in high-quality fish oil. The product is designed as a non-GMO, vegan, and sustainable alternative to fish oil, providing pet food manufacturers with a traceable, contaminant-free, and reliable source of EPA and DHA while enabling seamless replacement of fish oil in formulations.

Aker BioMarine

Aker BioMarine is a biotechnology company specializing in sustainably sourced marine ingredients, with a strong focus on krill-based omega-3 solutions for the human nutrition, dietary supplement, pharmaceutical, aquaculture, and animal nutrition markets. The company is recognized for its flagship Superba krill oil portfolio, which delivers phospholipid-bound EPA and DHA omega-3s with enhanced bioavailability. Through responsible krill harvesting, advanced processing technologies, and a fully integrated value chain, Aker BioMarine supports innovation in premium omega-3 ingredients while emphasizing sustainability and traceability. The company has a broad global presence across North America, Europe, Asia-Pacific, Latin America, and Australia, serving customers through an extensive international distribution and partnership network.

January 2026: Aker BioMarine strengthened its presence in the Indian omega-3 market ahead of Vitafoods India 2026 by introducing Revervia, a high-concentration algae-based DHA ingredient designed to meet the growing demand for sustainable and vegetarian omega-3 solutions. The company also expanded its market reach through a strategic distribution partnership with G.C. Chemie Pharmie and reinforced its local operations with new leadership appointments, supporting broader access to its krill oil and algae-derived omega-3 portfolio across India.

Pelagia

Pelagia is a leading producer of pelagic fish products for human consumption and a major supplier of marine-based ingredients, including protein concentrate, fishmeal, fish oil, and premium omega-3 solutions. Operating across Norway, the UK, Ireland, Denmark, and Ukraine, the company conducts its business through three divisions—Food, Feed, and Health. Its Health division is strengthened by Epax, a wholly owned subsidiary specializing in high-quality omega-3 ingredients for dietary supplements and pharmaceutical applications. With expertise in sustainable marine sourcing, advanced refining, and large-scale storage capabilities, Pelagia ensures a reliable supply of premium omega-3 products while emphasizing quality, traceability, innovation, and environmental responsibility to serve customers worldwide.

In April 2025, Epax, a subsidiary of Pelagia, launched EPAX Evolve 05, the world’s first commercially available VLC-PUFA (Very Long Chain Polyunsaturated Fatty Acid) product. VLC-PUFAs are a unique class of omega-3 fatty acids with promising benefits for vision, skin health, male fertility, bone density, and muscle strength, especially in the context of healthy aging. The product contains approximately ten times more VLC-PUFAs than crude fish oil and is part of Epax’s NovusLipid range. It has received GRAS status in the US and is a non-novel food approved in the EU, making it ready for market entry. This innovation stems from over a decade of research and patented technology developed by Epax to concentrate these rare fatty acids from fish oil.

Market Ranking

The omega-3 market is driven by increasing consumer demand for products backed by strong scientific evidence, clinically proven health benefits, and stability in various formulations. With growing interest in cardiovascular, brain, eye, and immune health, omega-3 has become a cornerstone ingredient across dietary supplements, functional foods, pharmaceuticals, and personal care, keeping the market highly competitive. Continuous innovation in extraction technologies, clinical validation, and sustainable sourcing strategies, particularly algae-based omega-3, is shaping the market dynamics and ensuring long-term growth.

The global omega-3 market is dominated by leading companies such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), and GOLDEN OMEGA (Chile). These key players leverage a mix of advanced purification processes, strong global supply chains, and broad product portfolios to cater to diverse end-user industries, including dietary supplements, functional foods and beverages, infant formula, pharmaceuticals, pet nutrition, and cosmetics. By focusing on sustainability, innovation, and clinical efficacy, these companies have secured a competitive advantage in the global omega-3 market. Their ability to diversify product applications, from concentrated fish oils and krill oils to algae-derived alternatives, positions them at the forefront of serving the rising demand for natural, science-backed, and versatile health ingredients.

Smaller companies and emerging startups are capitalizing on the growing demand for omega-3 by developing innovative formulations, sustainable sourcing methods, and novel delivery formats such as gummies, emulsions, and fortified beverages. While their current market share remains relatively limited compared to established players, these companies bring agility, creativity, and disruptive technologies that add to the overall dynamism of the omega-3 sector. Collaborations with research institutions and partnerships with larger industry players are further supporting their expansion. With rising investment flows, increased clinical validation, and focused marketing strategies aimed at consumer awareness, these companies are well-positioned to accelerate their growth and carve out a niche in the global omega-3 market.

Related Reports:

Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]